Gadopentetate dimeglumine - Sanochemia Pharmazeutika

Drug Profile

Gadopentetate dimeglumine - Sanochemia Pharmazeutika

Alternative Names: Magnetolux; MR-Lux

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sanochemia Pharmazeutika
  • Class Contrast media; Hexosamines; Organometallic compounds
  • Mechanism of Action Magnetic resonance imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Cancer; Inflammation; Vascular disorders

Most Recent Events

  • 30 Apr 2015 Launched for Cancer (Diagnosis) in Greece (IV) before April 2015
  • 30 Apr 2015 Launched for Inflammation (Diagnosis) in Greece (IV) before April 2015
  • 30 Apr 2015 Launched for Vascular disorders (Diagnosis) in Greece (IV) before April 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top